association

Full identifier: http://purl.org/np/RAkipqPTQ7TjgGtL0I8uP0rWaFcX-rMElSMMUeWjDXa6g#association

Assigned to 1 class:

Minted in Nanopublication

 RAkipqPTQ7 comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAkipqPTQ7... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-12T16:29:21.636+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAkipqPTQ7... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAkipqPTQ7... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAkipqPTQ7... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:29:21.636Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
thalomid in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma mm 1 1 thalomid is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum enl 1 2 thalomid in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma mm see clinical studies 14 1 thalomid is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum enl thalomid is not indicated as monotherapy for such enl treatment in the presence of moderate to severe neuritis thalomid is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of enl recurrence see clinical studies 14 2
Leoni Bücken
2021-06-12T14:29:21.636Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:29:21.636Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:29:21.636Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:29:21.636Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:29:21.636Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:29:21.636Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:29:21.636Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)